Immatics (IMTX) Short Interest Ratio & Short Volume $4.50 -0.14 (-2.92%) As of 11:46 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Immatics Short Interest DataImmatics (IMTX) has a short interest of 8.65 million shares, representing 7.49% of the float (the number of shares available for trading by the public). This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 8.9, indicating that it would take 8.9 days of the average trading volume of 621,463 shares to cover all short positions.Current Short Interest8,650,000 sharesPrevious Short Interest8,650,000 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$39.36 millionShort Interest Ratio8.9 Days to CoverLast Record DateMarch 15, 2025Outstanding Shares119,356,000 sharesShort Percent of Float7.49%Today's Trading Volume88,085 sharesAverage Trading Volume621,463 sharesToday's Volume Vs. Average14% Short Selling Immatics? Sign up to receive the latest short interest report for Immatics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartIMTX Short Interest Over TimeIMTX Days to Cover Over TimeIMTX Percentage of Float Shorted Over Time Remove Ads Immatics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/20258,650,000 shares $39.36 million No Change7.5%8.9 $4.55 2/28/20258,650,000 shares $37.89 million -1.9%7.5%9.2 $4.38 2/15/20258,820,000 shares $44.54 million -11.9%7.6%9.3 $5.05 1/31/202510,010,000 shares $54.75 million -4.6%N/A11.1 $5.47 1/15/202510,490,000 shares $60.32 million +9.6%N/A14.2 $5.75 12/31/20249,570,000 shares $68.04 million +13.1%N/A12.4 $7.11 12/15/20248,460,000 shares $61.00 million +3.3%N/A13.8 $7.21 11/30/20248,190,000 shares $68.14 million +6.4%N/A13.7 $8.32 11/15/20247,700,000 shares $62.91 million +15.1%N/A12.8 $8.17 10/31/20246,690,000 shares $60.88 million -33.2%N/A13.2 $9.10 Get the Latest News and Ratings for IMTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Immatics and its competitors with MarketBeat's FREE daily newsletter. 10/15/202410,020,000 shares $95.09 million +5.3%N/A20.6 $9.49 9/30/20249,520,000 shares $108.62 million -11.9%N/A29.4 $11.41 9/15/202410,800,000 shares $136.94 million +3.7%N/A33.4 $12.68 8/31/202410,420,000 shares $115.56 million +1.2%N/A31.2 $11.09 8/15/202410,300,000 shares $118.45 million +0.2%N/A24.6 $11.50 7/31/202410,280,000 shares $123.57 million +2.9%N/A21.3 $12.02 7/15/20249,990,000 shares $125.47 million +4.7%N/A20 $12.56 6/30/20249,540,000 shares $110.85 million -3.1%N/A18.9 $11.62 6/15/20249,840,000 shares $128.12 million -0.2%N/A18.5 $13.02 5/31/20249,860,000 shares $108.76 million +13.3%N/A17.5 $11.03 5/15/20248,700,000 shares $96.40 million -2.1%N/A17.7 $11.08 4/30/20248,890,000 shares $88.28 million -0.9%N/A21.4 $9.93 4/15/20248,970,000 shares $93.29 million +0.7%N/A20.7 $10.40 3/31/20248,910,000 shares $93.64 million +6.2%N/A16.9 $10.51 3/15/20248,390,000 shares $100.76 million +4.5%N/A16.7 $12.01 2/29/20248,030,000 shares $100.46 million +1.3%N/A16.2 $12.51 2/15/20247,930,000 shares $91.12 million -0.4%N/A16.7 $11.49 1/31/20247,960,000 shares $90.43 million +1.1%N/A15.2 $11.36 1/15/20247,870,000 shares $98.77 million +1.2%15.5%14 $12.55 12/31/20237,780,000 shares $81.92 million +36.5%15.3%15.6 $10.53 12/15/20235,700,000 shares $55.92 million +5.8%11.2%11.3 $9.81 11/30/20235,390,000 shares $47.65 million -0.9%10.6%11.2 $8.84 11/15/20235,440,000 shares $48.58 million -10.2%10.7%11.6 $8.93 10/31/20236,060,000 shares $46.36 million -1.8%11.9%14.2 $7.65 10/15/20236,170,000 shares $60.47 million -5.8%12.1%16.3 $9.80 9/30/20236,550,000 shares $75.85 million +11.4%12.8%18.2 $11.58 9/15/20235,880,000 shares $71.68 million -1.8%11.5%17.9 $12.19 8/31/20235,990,000 shares $70.92 million -3.2%12.1%15.5 $11.84 8/15/20236,190,000 shares $72.55 million -4.3%12.5%14.6 $11.72 7/31/20236,470,000 shares $77.06 million -3.4%12.4%14.9 $11.91While Markets Slide, These "Genesis Cog" Trades Are Up Double-Digits (Ad)While most investors are struggling in today's volatile market, a small group of traders are quietly booking consistent gains. Just last week, our Genesis Cog subscribers captured an 11.51% gain shorting JEF, another 8.57% on CAKE, and 4.78% on RJF—all while the broader indexes continued their downward trend.Click here to discover how the Genesis Cog works in falling markets 7/15/20236,700,000 shares $75.38 million +1.2%12.9%14 $11.25 6/30/20236,620,000 shares $76.39 million +4.8%12.7%13.5 $11.54 6/15/20236,320,000 shares $74.77 million +30.9%12.1%12.4 $11.83 5/31/20234,830,000 shares $47.67 million +9.3%8.8%11.2 $9.87 5/15/20234,420,000 shares $44.38 million +28.1%8.1%11.9 $10.04 4/30/20233,450,000 shares $24.67 million +26.8%6.1%9.7 $7.15 4/15/20232,720,000 shares $16.95 million -8.1%4.8%10 $6.23 3/31/20232,960,000 shares $20.42 million -0.3%5.2%11.7 $6.90 3/15/20232,970,000 shares $22.72 million +1.4%5.2%13.6 $7.65 2/28/20232,930,000 shares $24.82 million +8.9%5.2%14.8 $8.47 2/15/20232,690,000 shares $21.44 million -7.6%4.8%13.8 $7.97 1/31/20232,910,000 shares $23.60 million +2.1%5.0%15.7 $8.11 1/15/20232,850,000 shares $25.08 million -2.4%4.9%17.4 $8.80 12/30/20222,920,000 shares $25.43 million +2.1%5.0%17.3 $8.71 12/15/20222,860,000 shares $26.63 million +6.7%4.9%17.4 $9.31 11/30/20222,680,000 shares $28.25 million -6.0%4.6%14.7 $10.54 11/15/20222,850,000 shares $30.24 million +0.4%4.9%13.1 $10.61 10/31/20222,840,000 shares $32.09 million -1.7%5.0%12 $11.30 10/15/20222,890,000 shares $32.05 million +4.7%5.3%11.1 $11.09 9/30/20222,760,000 shares $27.60 million -12.7%6.0%9.5 $10.00 9/15/20223,160,000 shares $34.19 million +9.7%6.8%11.9 $10.82 8/31/20222,880,000 shares $36.75 million +2.5%6.3%11.3 $12.76 8/15/20222,810,000 shares $32.88 million +4.5%6.8%13.1 $11.70 7/31/20222,690,000 shares $29.86 million +9.4%6.7%12.7 $11.10 7/15/20222,460,000 shares $21.21 million -8.6%6.1%13.3 $8.62 6/30/20222,690,000 shares $23.43 million No Change6.7%17.9 $8.71 6/15/20222,690,000 shares $22.08 million +5.1%6.7%14.7 $8.21 5/31/20222,560,000 shares $18.61 million -8.6%6.4%14.5 $7.27 5/15/20222,800,000 shares $19.26 million -5.4%7.0%17.4 $6.88 4/30/20222,960,000 shares $23.00 million -3.0%7.3%20.2 $7.77 4/15/20223,050,000 shares $26.60 million +8.2%7.5%20.2 $8.72 3/31/20222,820,000 shares $22.53 million +1.1%7.0%19 $7.99 3/15/20222,790,000 shares $18.86 million -3.5%6.9%23.2 $6.76 2/28/20222,890,000 shares $23.12 million -4.9%7.1%22.5 $8.00 2/15/20223,040,000 shares $27.76 million -6.5%7.5%23.1 $9.13 1/31/20223,250,000 shares $32.79 million -7.7%7.8%18.8 $10.09 1/15/20223,520,000 shares $41.78 million No ChangeN/A19.4 $11.87 12/31/20213,520,000 shares $47.31 million +2.6%8.4%20 $13.44 12/15/20213,430,000 shares $42.63 million -2.0%8.2%19 $12.43 11/30/20213,500,000 shares $39.80 million +5.1%8.4%20.9 $11.37 11/15/20213,330,000 shares $39.73 million +4.7%8.0%18.7 $11.93 10/29/20213,180,000 shares $45.57 million +8.2%7.6%18.6 $14.33 10/15/20212,940,000 shares $40.72 million +20.0%7.0%23.1 $13.85 9/30/20212,450,000 shares $31.85 million +8.4%5.9%20.1 $13.00 9/15/20212,260,000 shares $33.06 million +9.2%5.4%20.1 $14.63 8/31/20212,070,000 shares $27.49 million +1.0%5.0%19 $13.28 8/13/20212,050,000 shares $24.60 million +9.0%4.9%21 $12.00 7/30/20211,880,000 shares $22.95 million No Change4.5%20.1 $12.21 7/15/20211,880,000 shares $22.41 million -2.1%4.5%17.5 $11.92 6/30/20211,920,000 shares $22.29 million +2.1%4.6%16.6 $11.61While Markets Slide, These "Genesis Cog" Trades Are Up Double-Digits (Ad)While most investors are struggling in today's volatile market, a small group of traders are quietly booking consistent gains. Just last week, our Genesis Cog subscribers captured an 11.51% gain shorting JEF, another 8.57% on CAKE, and 4.78% on RJF—all while the broader indexes continued their downward trend.Click here to discover how the Genesis Cog works in falling markets 6/15/20211,880,000 shares $22.17 million -0.5%4.5%13.2 $11.79 5/28/20211,890,000 shares $21.22 million +0.5%4.5%2.4 $11.23 5/14/20211,880,000 shares $19.61 million +1.1%4.5%2.4 $10.43 4/30/20211,860,000 shares $23.31 million -4.1%4.4%2.3 $12.53 4/15/20211,940,000 shares $23.42 million +3.7%4.6%2.5 $12.07 3/31/20211,870,000 shares $21.84 million +97.9%4.5%2.4 $11.68 3/15/2021944,900 shares $10.35 million -6.5%2.9%1.2 $10.95 2/26/20211,010,000 shares $11.08 million +2.7%3.1%7.5 $10.97 2/12/2021983,900 shares $11.26 million -1.6%3.0%8.6 $11.44 1/29/20211,000,000 shares $10.30 million +11.9%3.4%8.6 $10.30 1/15/2021893,300 shares $10.20 million No Change3.0%7.7 $11.42 IMTX Short Interest - Frequently Asked Questions What is Immatics' current short interest? Short interest is the volume of Immatics shares that have been sold short but have not yet been covered or closed out. As of March 15th, traders have sold 8,650,000 shares of IMTX short. 7.49% of Immatics' shares are currently sold short. Learn More on Immatics' current short interest. What is a good short interest ratio for Immatics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IMTX shares currently have a short interest ratio of 9.0. Learn More on Immatics's short interest ratio. Which institutional investors are shorting Immatics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Immatics: Group One Trading LLC, Caption Management LLC, Citadel Advisors LLC, and Jane Street Group LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Immatics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.49% of Immatics' floating shares are currently sold short. How does Immatics' short interest compare to its competitors? 7.49% of Immatics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Immatics: Mirum Pharmaceuticals, Inc. (16.96%), Edgewise Therapeutics, Inc. (13.52%), Centessa Pharmaceuticals plc (6.05%), Kymera Therapeutics, Inc. (14.38%), CG Oncology, Inc. (15.58%), Denali Therapeutics Inc. (8.36%), Belite Bio, Inc (0.32%), Arrowhead Pharmaceuticals, Inc. (8.65%), Arcutis Biotherapeutics, Inc. (14.26%), Tarsus Pharmaceuticals, Inc. (21.10%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), MicroStrategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks. What does it mean to sell short Immatics stock? Short selling IMTX is an investing strategy that aims to generate trading profit from Immatics as its price is falling. IMTX shares are trading down $0.14 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Immatics? A short squeeze for Immatics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of IMTX, which in turn drives the price of the stock up even further. How often is Immatics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IMTX, twice per month. The most recent reporting period available is March, 15 2025. More Short Interest Resources from MarketBeat Related Companies Mirum Pharmaceuticals Short Interest Data Edgewise Therapeutics Short Interest Data Centessa Pharmaceuticals Short Interest Data Kymera Therapeutics Short Interest Data CG Oncology Short Interest Data Denali Therapeutics Short Interest Data Belite Bio Short Interest Data Arrowhead Pharmaceuticals Short Interest Data Arcutis Biotherapeutics Short Interest Data Tarsus Pharmaceuticals Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:IMTX) was last updated on 3/31/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Great Society Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immatics Please log in to your account or sign up in order to add this asset to your watchlist. Share Immatics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
